Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping  Saleh Omairi,

Slides:



Advertisements
Similar presentations
Molecular Therapy - Nucleic Acids
Advertisements

Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Figure 2. Macrophages in dystrophic muscle in vivo and in vitro express Klotho. (A) A cross-section of 4-week-old mdx muscle labeled with antibodies to.
Molecular Therapy - Nucleic Acids
Volume 18, Issue 3, Pages (September 2013)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model  Karima Relizani, Graziella Griffith,
An herbal medicine, Go-sha-jinki-gan (GJG), increases muscle weight in severe muscle dystrophy model mice  Yusei Takemoto, Shoya Inaba, Lidan Zhang, Kousuke.
Molecular Therapy - Nucleic Acids
Molecular Therapy - Methods & Clinical Development
Volume 25, Issue 6, Pages (June 2017)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Jason.
Volume 22, Issue 7, Pages (July 2014)
Volume 13, Issue 10, Pages (December 2015)
Fig. 1. Generation of the ΔEx50 mouse model.
A Metabolic Basis for Endothelial-to-Mesenchymal Transition
Molecular Therapy - Nucleic Acids
Helena M. Viola et al. BTS 2018;3:
Selection and Identification of Skeletal-Muscle-Targeted RNA Aptamers
Volume 26, Issue 1, Pages (January 2018)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
Volume 10, Issue 2, Pages (February 2018)
Volume 25, Issue 3, Pages (March 2017)
Volume 17, Issue 10, Pages (October 2009)
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma  Alessandra Lopes, Kevin Vanvarenberg, Véronique Préat,
Volume 8, Issue 2, Pages (February 2017)
Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells  G-One Ahn,
Volume 24, Issue 11, Pages (November 2016)
Molecular Therapy - Nucleic Acids
Volume 11, Issue 3, Pages (September 2006)
Development of Novel Micro-dystrophins with Enhanced Functionality
Julia Ma, Christophe Pichavant, Haley du Bois, Mital Bhakta, Michele P
Volume 18, Issue 1, Pages (January 2010)
Volume 10, Issue 4, Pages (April 2018)
Volume 16, Issue 4, Pages (April 2008)
Volume 25, Issue 8, Pages (August 2017)
Molecular Therapy - Nucleic Acids
Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160
Muscle Satellite Cells Are Primed for Myogenesis but Maintain Quiescence with Sequestration of Myf5 mRNA Targeted by microRNA-31 in mRNP Granules  Colin G.
Volume 25, Issue 4, Pages (April 2017)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
by Christopher E. Nelson, Chady H. Hakim, David G
Volume 26, Issue 6, Pages (June 2018)
Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia  Raquel Vinhas, Alexandra R.
Volume 26, Issue 4, Pages e4 (January 2019)
Molecular Therapy - Methods & Clinical Development
Volume 23, Issue 8, Pages (August 2015)
Fig. 1. Generation of the ΔEx50 mouse model.
Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy  Pam M Van Ry, Ryan D.
Hepatocyte Growth Factor Regulates the miR-206-HDAC4 Cascade to Control Neurogenic Muscle Atrophy following Surgical Denervation in Mice  Wooshik Choi,
Gang Han, Caorui Lin, Hanhan Ning, Xianjun Gao, HaiFang Yin 
Volume 8, Issue 1, Pages (July 2003)
Volume 10, Issue 5, Pages (November 2004)
A user's perspective on GeoMxTM digital spatial profiling
Arati Sridharan, Chetan Patel, Jit Muthuswamy 
Molecular Therapy - Nucleic Acids
Volume 26, Issue 4, Pages (April 2018)
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy  Joshua J.A. Lee, Rika Maruyama,
Volume 17, Issue 5, Pages (May 2009)
Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6
Fig. 4 Systemic AAV9 delivery of gene editing components to ΔEx44 mice rescues dystrophin expression. Systemic AAV9 delivery of gene editing components.
Molecular Therapy - Methods & Clinical Development
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Fig. 3 Correction of Dmd exon 44 deletion in mice by intramuscular AAV9 delivery of gene editing components. Correction of Dmd exon 44 deletion in mice.
Presentation transcript:

Link between MHC Fiber Type and Restoration of Dystrophin Expression and Key Components of the DAPC by Tricyclo-DNA-Mediated Exon Skipping  Saleh Omairi, Kwan-Leong Hau, Henry Collin-Hooper, Federica Montanaro, Aurelie Goyenvalle, Luis Garcia, Ketan Patel  Molecular Therapy - Nucleic Acids  Volume 9, Pages 409-418 (December 2017) DOI: 10.1016/j.omtn.2017.10.014 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Myosin Heavy Chain Profile of the Tibialis Anterior Muscle (A) Immunohistochemical images of TA muscle from 20- to 22-week-old male wild-type, mdx, and tc-DNA-treated mdx mice. Green fibers signify the expression of MHCIIA with MHCIIB appearing as red. Non-green and red fibers represent MHCIIX. (B) MHC profile in the three cohorts. Results show that WT, mdx, and tc-DNA-treated mdx mice have the same proportion of each MHC subtype (n = 4 for each cohort). Statistical analysis was performed by one-way ANOVA followed by Bonferroni correction for multiple comparison. Molecular Therapy - Nucleic Acids 2017 9, 409-418DOI: (10.1016/j.omtn.2017.10.014) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Expression of Dystrophin, β-Sacroglycan, nNOS, and α-Dystroglycan in the TA Muscle of 20- to 22-Week-Old Male mdx Mice (A) Each row shows the entire TA muscle stained for one of the four molecules together with a magnified detailed image. All positive fibers were correlated to the expression of an MHC isoform, and their distribution is given as the total number as well as proportion to the frequency of the MHC isoform. (B) Graph showing the proportion of TA fibers expressing the four investigated molecules (n = 4 for each cohort). *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical analysis was performed by one-way ANOVA followed by Bonferroni correction for multiple comparison. Molecular Therapy - Nucleic Acids 2017 9, 409-418DOI: (10.1016/j.omtn.2017.10.014) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Expression of Dystrophin, β-Sarcoglycan, nNOS, and α-Dystroglycan in the TA Muscle of 20- to 22-Week-Old Male tc-DNA-Treated mdx Mice (A) Each row shows the entire TA muscle immunostained for dystrophin, β-sarcoglycan, nNOS, and α-dystroglycan together with a magnified detailed image. All positive fibers were correlated to the expression of an MHC isoform, and their distribution is given as the total number as well as proportion to the frequency of the MHC isoform. (B) Graph showing the proportion of TA fibers from tc-DNA-treated mdx mice expressing the four investigated molecules (n = 4 for each cohort). *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical analysis was performed by one-way ANOVA followed by Bonferroni correction for multiple comparison. Molecular Therapy - Nucleic Acids 2017 9, 409-418DOI: (10.1016/j.omtn.2017.10.014) Copyright © 2017 The Authors Terms and Conditions

Figure 4 Semiquantitative Analysis of DAPC Restoration following tc-DNA Treatment of 20- to 22-Week-Old Male mdx Mice Untreated and tc-DNA-treated muscle shows high levels of individual proteins in MHCIIA fibers (white arrows) compared to MHCIIB fibers (yellow arrows). Intensities from over 30 regions for each fiber type were taken from revertant untreated mdx and set to a reference value of one. Similar numbers of intensity readings were plotted for each fiber type from tc-DNA-treated mdx muscle. In all cases there was a significant increase in intensity compared to untreated revertant fibers of the same MHC type. Thickness of expression domain was measured and plotted for each MHC isoform originating from revertant untreated mdx and tc-DNA-treated mdx muscle. MHCIIA fibers had thicker expression domains compared to MHCIIB. Thickness for expression domains irrespective of MHC fiber type was increased by tc-DNA treatment (n = 4 for each cohort). Scale bar applicable to all images represents 50 μm. *p < 0.05, **p < 0.01, and ***p < 0.001. Statistical analysis was performed using two-tailed t test. Molecular Therapy - Nucleic Acids 2017 9, 409-418DOI: (10.1016/j.omtn.2017.10.014) Copyright © 2017 The Authors Terms and Conditions

Figure 5 Western Blot Analysis of DAPC Proteins in 20- to 22-Week-Old Male Mice (A) Western blot image of DAPC proteins in the TA muscle. (B) Quantification of DAPC proteins relative to GAPDH. Note the robust expression of β-sarcoglycan, nNOS, and α-dystroglycan in untreated mdx muscle (n = 3 for each cohort). **p < 0.01. Statistical analysis was performed using two-tailed t test. Molecular Therapy - Nucleic Acids 2017 9, 409-418DOI: (10.1016/j.omtn.2017.10.014) Copyright © 2017 The Authors Terms and Conditions